1. Market Research
  2. > Healthcare Market Trends
  3. > Cameroon Pharmaceuticals and Healthcare Report Q3 2015

Cameroon Pharmaceuticals and Healthcare Report Q3 2015

  • May 2015
  • -
  • Business Monitor International
  • -
  • 60 pages

BMI View:


Headline Expenditure Projections
- Pharmaceuticals: XAF170.33bn (USD348mn) in 2014 to XAF187.60bn (USD315mn) in 2015; +10.1% in local currency terms and -9.6% in US dollar terms. Forecast revised downwards from last quarter.
- Healthcare: XAF802.48bn (USD1.64bn) in 2014 to XAF875.24bn (USD1.47bn) in 2015; +9.1% in local currency terms and -10.5% in US dollar terms. Forecast revised upwards from last quarter.

Risk/Reward Indices: In Q3 2015, Cameroon shifted upwards three ranking positions to 24 from 27 in the last quarter out of 31 markets in the Middle East and Africa region under BMI's Risk Reward Index matrix. However, posting a score of 32.2 out of 100, Cameroon registered a downward revision in its overall score from 32.6 in the last quarter. While Cameroon's revised score reflects lower industry growth indices, the ranking variations are explained by deteriorating scores in peer countries. Cameroon's score is driven by significant population growth (scoring 4.5 out of 5), and mild sector value growth (scoring 6.0 out of 12), but dragged down by low per capita spending level (scoring 1.2 out 12) and market expenditure (scoring 4.0 out of 20).

Table Of Contents

Cameroon Pharmaceuticals and Healthcare Report Q3 2015
BMI Industry View ... 7
SWOT 9
Political . 10
Economic ... 11
Operational Risk . 12
Industry Forecast .. 14
Pharmaceutical Market Forecast 14
Table: Pharmaceutical Sales, Historical Data And Forecasts (Cameroon 2011-2019)...............15
Healthcare Market Forecast .. 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2011-2019)............. . 20
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2011-2019).........20
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Cameroon 2011-2019)........... 20
Macroeconomic Forecasts ... 21
Economic Analysis ... 21
Table: Economic Activity (Cameroon 2010-2019)......................... . 26
Industry Risk Reward Ratings .. 27
Middle East And Africa Risk/Reward Index .. 27
Cameroon Risk/Reward Index 35
Rewards ... 35
Risks 35
Market Overview ... 37
Industry Trends And Developments 38
Epidemiology 38
Healthcare Sector .. 39
Healthcare Sector Developments ... 40
Regulatory Development .. 44
Competitive Landscape 45
Pharmaceutical Industry . 45
Pharmaceutical Sector Developments 45
Demographic Forecast . 49
Table: Population Headline Indicators (Cameroon 1990-2025).....................50
Table: Key Population Ratios (Cameroon 1990-2025)........................ . 50
Table: Urban/Rural Population and Life Expectancy (Cameroon 1990-2025).................. . . 51
Table: Population By Age Group (Cameroon 1990-2025)....................... . 51
Table: Population By Age Group % (Cameroon 1990-2025)...................... . . 52
Glossary . 54
Methodology .. 56
Pharmaceutical Expenditure Forecast Model .. 56
Healthcare Expenditure Forecast Model . 56
Notes On Methodology 57
Risk/Reward Index Methodology ... 58
Index Overview .. 59
Table: Pharmaceutical Risk/Reward Index Indicators........................ . 59
Indicator Weightings .. 60

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • May 2015
  • by Global Data

PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2023 Summary Glaucoma is a leading cause of preventable blindness globally. This chronic progressive optic neuropathy causes irreversible ...

Cancer Treatment Drugs Markets in China

Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • June 2015
  • by Asia Market Information & Development Company

China's demand for Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed ...

Blood Products  Markets in China

Blood Products Markets in China

  • $ 4 000
  • Industry report
  • July 2015
  • by Asia Market Information & Development Company

China's demand for Blood Products has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which ...

Health Care Markets In China

June 2015 $ 4 000

Anti-tumor Drugs Markets In China

August 2015 $ 4 000

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.